Jennifer Delaney-Davis
Adult Health · Ocean Springs, MSNPI 1821537200
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by United Therapeutics Corporation at 46.9% of the total. Among adult health clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $42.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$4K
- Inspire Medical Systems, Inc.$1K
- AstraZeneca$731
- Actelion Pharmaceuticals US, Inc.$427
- Boehringer Ingelheim$339
- GSK$228
- plus $2K from 22 others
What the payments were for
- Consulting fees$87510%
- Travel & lodging$3,18536%
- Food & beverage$4,56452%
- Education$1322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 37 | $4,105 |
| Inspire Medical Systems, Inc. | 8 | $1,349 |
| AstraZeneca(2 entities) | 24 | $731 |
| Actelion Pharmaceuticals US, Inc. | 12 | $427 |
| Boehringer Ingelheim | 24 | $339 |
| GSK | 19 | $228 |
| Grifols USA, LLC | 10 | $196 |
| Electromed, Inc. | 24 | $164 |
| Mallinckrodt Hospital Products Inc. | 4 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $145 |
| Amgen | 1 | $118 |
| Radius Health, Inc. | 1 | $115 |
| Verona Pharma, Inc. | 1 | $110 |
| Mylan Specialty L.p. | 6 | $91 |
| Sanofi | 5 | $84 |
| Jazz Pharmaceuticals Inc. | 4 | $70 |
| Genentech USA, Inc. | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Sandoz | 2 | $33 |
| Insmed, Inc. | 2 | $32 |
| Advanced Respiratory, Inc | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Inogen, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Breas Medical, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Gilead | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,757 in reported general payments places this provider in the 95th percentile of 93 adult health providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 52 | $633,104 |
| Tyvaso DpiTreprostinil | 17 | $418,351 |
| AdempasRiociguat | 22 | $299,238 |
| TracleerBosentan | 13 | $299,198 |
| UptraviSelexipag | 12 | $293,458 |
| OfevNintedanib Esylate | 12 | $158,821 |
| Tadalafil | 26 | $27,206 |
| Ambrisentan | 18 | $23,979 |
| Sildenafil Citrate | 38 | $18,522 |
| Famotidine | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Opsumit, Tracleer, Uptravi | $427 | $1,225,75977 claims |
| BayerAdempas | $14 | $299,23822 claims |
| Boehringer IngelheimOfev | $339 | $158,82112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 adult health providers in Mississippi.
Other adult health in Ocean Springs
- Jennah AtwoodOcean Springs$2K
- Carly SolomonOcean Springs$520
- Patricia LewisOcean Springs$280
- Amanda GreeneRidgeland$108K
- Rhonda HickmanTupelo$15K
- Angela SlaterFlorence$14K
- Traci EvansGulfport$8K
- Casey AdamsGulfport$8K
- Keila BrownJackson$7K
- Brandi JohnstonJackson$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.